Health Record Sample Clauses

Health Record. Any written, printed or electronically recorded material maintained by a health care entity in the course of providing health services to an individual concerning the individual and the services provided. "Health Record" also includes the substance of any communication made by an individual to a health care entity in confidence during or in connection with the provision of health services or information otherwise acquired by the health care entity about an individual in confidence and in connection with the provision of health services to the individual. (Code § 32.1- 127.1:03)
AutoNDA by SimpleDocs
Health Record. The above-described kitten has had age appropriate vaccination(s) and preventative worming(s), which have been documented in the health record book provided to Buyer. Seller is not responsible for parasites or disease that this kitten may contract through transportation from Sweetharmonys Persians & Exotic Shorthair to the Buyer's home.
Health Record. The child/young person must be accompanied by their health record. The health status and medical needs of the child must be established at the time of placement.
Health Record. This should include a record of any health-related activities (deworming, vaccination, medicated feeds, or use of veterinarian’s services for any reason.) This should include what you used, how much you used, and what you used it for. Include any well-animal care such as a health certificate. Fill in all applicable information. If your animal is healthy throughout the project, make a note of that. Use “P” for preventive treatments. Fill out an Individual Animal Health Record and Treatment Map for each animal receiving treatment and for each health event (make copies as necessary.) Note: all health expenses should be listed under Non-Feed Expenses. *ROA: Rout of Administration (SQ, IM, IV, IN, topical, oral) • SQ - subcutaneous (under the skin) • IM - intramuscular (into a muscle) • IV - intravenous (into a vein) • Topical - (onto the skin) • Oral - (ingested) Individual Cattle Health Record and Treatment Map Fill out a health record and treatment map for each health event by date. Whenever possible select SQ* product and never give injection in the rear leg or top butt. Animal Description ID/Brand Animal Age Weight Temperature Treatment Date Administered by (name) Indicate site of treatment with the corresponding # from the table. Site # Product/ Company Lot or Serial # Exp. Date ROA* Dose Booster Date Withdrawal Date
Health Record. All children attending schools in New Jersey must have their physician complete a Universal Child Health Care Record PRIOR to enrollment. IMMUNIZATION POLICYImmunization records must be kept up to date. When you take your child to the doctor, we must be provided with an updated copy of their immunizations. All children under the age of 60 months must have a flu vaccine in order to attend any facility in New Jersey. The vaccine must be received no later than December 31, 2013. The town audits our files every fall. If you have not provided us with updated records please do so no later than October 24, 2013. Should you want your physician to fax forms to us, our fax number is, 973-230- 0447. Failure to provide this information could result in your child not being able to attend our center or any center in the state. ALLERGIES, ASTHMA, SEIZURES – At the time of registration, we must be notified if your child has any of these conditions listed above. An ACTION PLAN MUST BE SUPPLIED FOR ANY CHILDREN WITH THESE CONDITIONS. We are prohibited from administering any medication (EPIPen, nebulizer medication or Seizure medication) unless we have a complete Action Plan on file. These plans must be updated yearly.
Health Record. Users can enter their personal health information including demographics, allergy history, immunizations, and more. All the information stored can be utilized during the screening process making the referral even more accurate and customized to the individual.
Health Record. Practices need to ensure that the current immunisation status of each child is recorded in the GP-held lifelong record. This should include a record of any parent or guardian refusing to give permission for immunisation and all information and advice given to the parent or guardian involved. Adverse reactions to immunisations must also be recorded. Practices must ensure that details of the patients’ monitoring as part of the NES is included in their life-long record. If the patient is not registered with the practice providing the NES, then the practice must send this information to the patient’s registered practice for inclusion in the patient record. The Child Health Records Department should also be informed of all immunisations undertaken.
AutoNDA by SimpleDocs

Related to Health Record

  • Health Care Compliance Neither the Company nor any Affiliate has, prior to the Effective Time and in any material respect, violated any of the health care continuation requirements of COBRA, the requirements of FMLA, the requirements of the Health Insurance Portability and Accountability Act of 1996, the requirements of the Women's Health and Cancer Rights Act of 1998, the requirements of the Newborns' and Mothers' Health Protection Act of 1996, or any amendment to each such act, or any similar provisions of state law applicable to its Employees.

  • HIPAA To the extent (if any) that DXC discloses “Protected Health Information” or “PHI” as defined in the HIPAA Privacy and Security Rules (45 CFR, Part 160-164) issued pursuant to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) to Supplier or Supplier accesses, maintains, uses, or discloses PHI in connection with the performance of Services or functions under this Agreement, Supplier will: (a) not use or further disclose PHI other than as permitted or required by this Agreement or as required by law; (b) use appropriate safeguards to prevent use or disclosure of PHI other than as provided for by this Agreement, including implementing requirements of the HIPAA Security Rule with regard to electronic PHI; (c) report to DXC any use or disclosure of PHI not provided for under this Agreement of which Supplier becomes aware, including breaches of unsecured protected health information as required by 45 CFR §164.410, (d) in accordance with 45 CFR §164.502(e)(1)(ii), ensure that any subcontractors or agents of Supplier that create, receive, maintain, or transmit PHI created, received, maintained or transmitted by Supplier on DXC’s behalf, agree to the same restrictions and conditions that apply to Supplier with respect of such PHI; (e) make available PHI in a Designated Record Set (if any is maintained by Supplier) in accordance with 45 CFR section 164.524;

  • Environmental, Health and Safety i. Environment, Health and Safety Performance. Seller acknowledges and accepts full and sole responsibility to maintain an environment, health and safety management system ("EMS") appropriate for its business throughout the performance of this Contract. Buyer expects that Seller’s EMS shall promote health and safety, environmental stewardship, and pollution prevention by appropriate source reduction strategies. Seller shall convey the requirement of this clause to its suppliers. Seller shall not deliver goods that contain asbestos mineral fibers.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, Registration Statement, the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with applicable laws, rules, regulations and policies of the Food and Drug Administration of the U.S. Department of Health and Human Services (the “FDA”) or any committee thereof or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are materially inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Pricing Disclosure Package or the Prospectus; for such studies that have been or are being conducted, the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by foreign government or drug or medical device regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf of the Company or any of its subsidiaries with the FDA has been terminated or suspended by the FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or ongoing studies conducted or proposed to be conducted by or on behalf of the Company or any of its subsidiaries.

  • Access Control Supplier will maintain an appropriate access control policy that is designed to restrict access to Accenture Data and Supplier assets to authorized Personnel. Supplier will require that all accounts have complex passwords that contain letters, numbers, and special characters, be changed at least every 90 days, and have a minimum length of 8 characters.

  • Safety Where an employee is prevented from working at the employee’s particular function as a result of unsafe conditions caused by the inclement weather, the employee may be transferred to other work in the employee’s classification on site, until the unsafe conditions are rectified. Where such alternative is not available and until the unsafe conditions are rectified, the employee shall remain on site. The employee shall be paid for such time without reduction of the employees’ inclement weather entitlement.

  • Tests and Preclinical and Clinical Trials The studies, tests and preclinical and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all Authorizations and Applicable Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder (collectively, “FFDCA”); the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the General Disclosure Package and the Prospectus are, to the Company’s knowledge, accurate in all material respects and fairly present the data derived from such studies, tests and trials; except to the extent disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the Company is not aware of any studies, tests or trials, the results of which the Company believes reasonably call into question the study, test, or trial results described or referred to in the Registration Statement, the General Disclosure Package and the Prospectus when viewed in the context in which such results are described and the clinical state of development; and, except to the extent disclosed in the Registration Statement, the General Disclosure Package or the Prospectus, neither the Company nor any Subsidiary has received any notices or correspondence from the FDA or any Governmental Entity requiring the termination or suspension of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.

  • Certificate of Analysis Seller shall provide a certificate of analysis and other documents as defined in the Quality Agreement for any Product to be released hereunder, in a form in accordance with the cGMPs and all other applicable Regulatory Requirements and Product Specifications and as shall be agreed upon by the parties. For any batch that initially failed to meet any Product Specification, the certificate of analysis shall document the exception. Products that do not meet dissolution specifications at USP Stage I and II testing shall not be accepted by Buyer (and such requirement shall be included in the Product Specifications/Quality Manual).

  • Environment, Health, and Safety 24.4.1. The Supplier and its staff (and/or any sub-supplier and/or subcontractor) shall comply with the laws and regulations in force related to protection of the environment, the health and safety instructions applicable to the Goods and Services performed pursuant to the Contract and especially, if appropriate, to the Goodsand Services performedon any Site by a third company.

  • Environmental, Health and Safety Matters (a) The Company has complied and is in compliance with all Environmental, Health, and Safety Requirements.

Time is Money Join Law Insider Premium to draft better contracts faster.